Pilot Trial of Single Dose Ilofotase Alfa in Hypophosphatasia

Clinical trial NCT05890794 · COMPLETED

Trial details

NCT number: NCT05890794
Sponsor: AM-Pharma
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hypophosphatasia

Start date: 2023-05-15
Primary completion: 2023-07-07
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.